Search Results - saul+tzipori

2 Results Sort By:
Synthesis and Prophylactic Use of Humanized Neutralizing Monoclonal SLT-I and SLT-II Antibodies Against Hemolytic Uremic Syndrome (HUS) in Children.
The invention relates in one aspect to a therapeutic method to treat hemolytic uremic syndrome by administering to an individual a therapeutically effective amount of monoclonal antibody which binds specifically to either Shiga toxin, Shiga like toxin I or Shiga like toxin II. The hemolytic uremic syndrome is typically caused by an Enterohemorrhagic...
Published: 11/25/2022   |   Inventor(s): Saul Tzipori, Ramaswamy Balakrishnan, Arthur Donohue-Rolfe
Keywords(s):  
Category(s): Therapeutic
Spore Vaccine for Rotavirus
Heat-stable, injection-free vaccine platformThe invention is a novel vaccine platform utilizing the non-pathogenic bacterium Bacillus subtilis as the antigen-producer. A desired antigen can be engineered to be under the control of a pro-vegetative state or a pro-sporulation promoter. Cells are induced to express the desired antigen on the cell surface...
Published: 7/30/2021   |   Inventor(s): John Herrmann, Abraham Sonenshein, Saul Tzipori, Boris Belitsky
Keywords(s):  
Category(s): Therapeutic: vaccine